Marcus Magister, MD
Otolaryngology · Washington, PANPI 1053705962
Payments from drug & device makers
Across 25 payments — averaging $54.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$791
- Sanofi-aventis U.S. LLC$155
- Regeneron Healthcare Solutions, Inc.$154
- Medtronic$78
- GSK$41
- Phathom Pharmaceuticals, Inc.$35
- plus $105 from 4 others
What the payments were for
- Consulting fees$604%
- Travel & lodging$69151%
- Food & beverage$35126%
- Education$25319%
- Gifts$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 7 | $791 |
| Sanofi-aventis U.S. LLC | 2 | $155 |
| Regeneron Healthcare Solutions, Inc. | 3 | $154 |
| Medtronic | 2 | $78 |
| GSK | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
| Sanofi | 2 | $32 |
| Acclarent, Inc | 2 | $29 |
| Smith+Nephew | 2 | $28 |
| KARL Storz Endoscopy-america | 1 | $17 |
How this compares
$1,359 in reported general payments places this provider in the 55th percentile of 456 otolaryngology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 68 | $8,408 |
| Ipratropium Bromide | 70 | $1,252 |
| Fluticasone Propionate | 108 | $691 |
| Ofloxacin | 13 | $463 |
| SynthroidLevothyroxine Sodium | 11 | $425 |
| Famotidine | 70 | $365 |
| Levothyroxine Sodium | 41 | $312 |
| Omeprazole | 65 | $229 |
| Mupirocin | 41 | $182 |
| Pantoprazole Sodium | 34 | $164 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 22 | $149 |
| Prednisone | 23 | $35 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $30 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Washington
- Nancy SnydermanPhiladelphia$4.5M
- Joseph CurryPhiladelphia$2M
- David YenBethlehem$2M
- Stella LeePittsburgh$825K
- John GermillerPhiladelphia$825K
- Adam LuginbuhlPhiladelphia$745K
- Neerav GoyalHershey$640K
- David KennedyPhiladelphia$603K
- Richard SterlingPhiladelphia$378K
- Mauritis BoonPhiladelphia$363K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.